Cargando…

Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm

Although 5-fluorouracil (5-Fu) combination chemotherapy provides a satisfactory therapeutic response in patients with gestational trophoblastic neoplasms (GTNs), it has severe side effects. The current study analyzed the therapeutic effects and side effects of tegafur plus actinomycin D (Act-D) vs....

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Mei, Ding, Yiling, Yu, Ling, Deng, Yali, Lai, Weisi, Hu, Yun, Zhang, Hongwen, Wu, Xianqing, Fan, Hong, Ding, Hui, Wu, Yilin, Tao, Guangshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658150/ https://www.ncbi.nlm.nih.gov/pubmed/26599757 http://dx.doi.org/10.1371/journal.pone.0143531

Ejemplares similares

Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia
por: Xue, Wei, et al.
Publicado: (2023)

Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia
por: Paulino, Eduardo, et al.
Publicado: (2019)

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report
por: Mu, Xiyan, et al.
Publicado: (2018)

Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN)
por: Shahbazian, Nahid, et al.
Publicado: (2014)

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia
por: Li, Lei, et al.
Publicado: (2018)

Gestational trophoblastic neoplasm and women living with HIV and/or AIDS
por: Barnardt, Pieter, et al.
Publicado: (2015)

Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease
por: Lee, Young-Jae, et al.
Publicado: (2017)

Uterine Rupture Due to Invasive Metastatic Gestational Trophoblastic Neoplasm
por: Bruner, David I., et al.
Publicado: (2013)

Lack of a Y-Chromosomal Complement in the Majority of Gestational Trophoblastic Neoplasms
por: Yap, Kai Lee, et al.
Publicado: (2010)

Diagnosis and Management of Mixed Gestational Trophoblastic Neoplasia: A Study of 16 Cases and a Review of the Literature
por: Kong, Yujia, et al.
Publicado: (2019)

Progesterone Enhances the Invasion of Trophoblast Cells by Activating PI3K/AKT Signaling Pathway to Prevent Preeclampsia
por: Liu, Hongyu, et al.
Publicado: (2023)

Unusual Presentation of Hypothyroidism in a Pregnant Woman, Mimicking Gestational Trophoblastic Neoplasm
por: Aminimoghaddam, Soheila, et al.
Publicado: (2016)

Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms
por: Frega, G., et al.
Publicado: (2021)

A Well-Circumscribed Border with Peripheral Doppler Signal in Sonographic Image Distinguishes Epithelioid Trophoblastic Tumor from Other Gestational Trophoblastic Neoplasms
por: Qin, Jiale, et al.
Publicado: (2014)

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
por: Schink, Julian C., et al.
Publicado: (2020)

Discovery of actinomycin L, a new member of the actinomycin family of antibiotics
por: Machushynets, Nataliia V., et al.
Publicado: (2022)

Major surgeries performed for gestational trophoblastic neoplasms in a teaching hospital in Tehran, Iran
por: Ghaemmaghami, Fatemeh, et al.
Publicado: (2011)

Long-term outcomes of pregnant women with pulmonary hypertension diagnosed by echocardiography: a retrospective cohort study in a single center from China
por: Lai, Weisi, et al.
Publicado: (2021)

Tegafur-induced acral hyperpigmentation
por: Teixeira, Vera, et al.
Publicado: (2011)

Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies
por: Hao, Jiatao, et al.
Publicado: (2021)

Genetic interrelations in the actinomycin biosynthetic gene clusters of Streptomyces antibioticus IMRU 3720 and Streptomyces chrysomallus ATCC11523, producers of actinomycin X and actinomycin C
por: Crnovčić, Ivana, et al.
Publicado: (2017)

ON THE DIFFERENTIAL CYTOTOXICITY OF ACTINOMYCIN D
por: Sawicki, Stanley G., et al.
Publicado: (1971)

Human Trophoblast Neoplasms: Proceedings of the World Congress on Trophoblast Neoplasms, Nairobi, 1982. Advances in Experimental Medicine and Biology
por: Stirrat, G.M.
Publicado: (1985)

In vitro and in silico evaluations of actinomycin X(2)and actinomycin D as potent anti-tuberculosis agents
por: Qureshi, Kamal Ahmad, et al.
Publicado: (2023)

Gestational trophoblastic neoplasia in the 1990s.
por: Goldstein, D. P.
Publicado: (1991)

Gestational Trophoblastic Disease in Brazil
por: Braga, Antonio, et al.
Publicado: (2019)

Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy
por: Shiraiwa, Ken, et al.
Publicado: (2021)

Epigenetic Dysregulation of Trophoblastic Gene Expression in Gestational Trophoblastic Disease
por: Szabolcsi, Zoltan, et al.
Publicado: (2021)

Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, randomized trial
por: Jiang, Fang, et al.
Publicado: (2023)

Tegafur/gimeracil/oteracil‐induced eosinophilic pneumonia
por: Sumi, Toshiyuki, et al.
Publicado: (2020)

Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy
por: Cortés-Charry, R., et al.
Publicado: (2021)

Spontaneous regression of gestational trophoblastic neoplasia
por: Niimi, Kaoru, et al.
Publicado: (2017)

Understanding and management of gestational trophoblastic disease
por: Ning, Fen, et al.
Publicado: (2019)

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia
por: Blackwell, Conner, et al.
Publicado: (2023)

Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer
por: Hill, Christopher R., et al.
Publicado: (2014)

THE RADIOAUTOGRAPHIC DETECTION OF DNA WITH TRITIATED ACTINOMYCIN D
por: Camargo, E. Plessmann, et al.
Publicado: (1967)

ON THE RECOVERY OF TRANSCRIPTION AFTER INHIBITION BY ACTINOMYCIN D
por: Sawicki, Stanley G., et al.
Publicado: (1972)

Identification of microRNA signature in the progression of gestational trophoblastic disease
por: Zhao, Jiu-Ru, et al.
Publicado: (2018)

Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease
por: Ngu, Siew-Fei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d7h7u1btmhk9eojiqtcmr0sj1k